The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ruegg Curtis since 2014.
The trader's CIK number is 1597578.
At the time of the last reporting, Ruegg Curtis was the EVP R&D and Tech Operations of Revance Therapeutics, Inc.. (stock ticker symbol RVNC).
Also see all insider trading activities at Revance Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | RVNC | 0 | $0 | 7,000 | $158,230 | 7,000 | $60,900 |
| 2015 | RVNC | 0 | $0 | 19,500 | $513,831 | 19,500 | $130,049 |
| 2014 | RVNC | 0 | $0 | 6,500 | $120,338 | 5,662 | $14,437 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-06-13 | RVNC | Option Ex | 1,000 | 8.70 | 8,700 |
| 2016-06-13 | RVNC | Sale | 1,000 | 18.25 | 18,250 |
| 2016-05-09 | RVNC | Sale | 1,000 | 16.18 | 16,180 |
| 2016-05-09 | RVNC | Option Ex | 1,000 | 8.70 | 8,700 |
| 2016-04-11 | RVNC | Option Ex | 1,000 | 8.70 | 8,700 |
| 2016-04-11 | RVNC | Sale | 1,000 | 19.11 | 19,110 |
| 2016-03-07 | RVNC | Sale | 1,000 | 20.43 | 20,430 |
| 2016-03-07 | RVNC | Option Ex | 1,000 | 8.70 | 8,700 |
| 2016-02-08 | RVNC | Option Ex | 1,000 | 8.70 | 8,700 |
| 2016-02-08 | RVNC | Sale | 1,000 | 18.14 | 18,140 |
| 2016-01-06 | RVNC | Option Ex | 2,000 | 8.70 | 17,400 |
| 2016-01-06 | RVNC | Sale | 2,000 | 33.06 | 66,120 |
| 2015-08-17 | RVNC | Sale | 3,000 | 30.49 | 91,482 |
| 2015-08-17 | RVNC | Option Ex | 3,000 | 8.70 | 26,099 |
| 2015-07-17 | RVNC | Option Ex | 3,000 | 7.65 | 22,950 |
| 2015-07-17 | RVNC | Sale | 3,000 | 31.03 | 93,090 |
| 2015-06-17 | RVNC | Option Ex | 3,000 | 6.60 | 19,800 |
| 2015-06-17 | RVNC | Sale | 3,000 | 33.53 | 100,593 |
| 2015-06-03 | RVNC | Option Ex | 500 | 6.60 | 3,300 |
| 2015-06-03 | RVNC | Sale | 500 | 30.00 | 15,000 |
| 2015-05-18 | RVNC | Option Ex | 2,500 | 6.60 | 16,500 |
| 2015-05-18 | RVNC | Sale | 2,500 | 26.69 | 66,735 |
| 2015-05-15 | RVNC | Option Ex | 500 | 6.60 | 3,300 |
| 2015-05-15 | RVNC | Sale | 500 | 25.00 | 12,500 |
| 2015-04-17 | RVNC | Option Ex | 2,000 | 6.60 | 13,200 |
| 2015-04-17 | RVNC | Sale | 2,000 | 22.23 | 44,466 |
| 2015-03-19 | RVNC | Option Ex | 500 | 6.60 | 3,300 |
| 2015-03-19 | RVNC | Sale | 500 | 20.00 | 10,000 |
| 2015-03-17 | RVNC | Option Ex | 1,500 | 6.60 | 9,900 |
| 2015-03-17 | RVNC | Sale | 1,500 | 18.61 | 27,915 |
| 2015-03-09 | RVNC | Option Ex | 500 | 6.60 | 3,300 |
| 2015-03-09 | RVNC | Sale | 500 | 18.00 | 9,000 |
| 2015-02-17 | RVNC | Option Ex | 1,000 | 4.58 | 4,575 |
| 2015-02-17 | RVNC | Sale | 1,000 | 16.80 | 16,800 |
| 2015-01-20 | RVNC | Option Ex | 1,000 | 2.55 | 2,550 |
| 2015-01-20 | RVNC | Sale | 1,000 | 17.25 | 17,250 |
| 2015-01-09 | RVNC | Sale | 500 | 18.00 | 9,000 |
| 2015-01-09 | RVNC | Option Ex | 500 | 2.55 | 1,275 |
| 2014-12-17 | RVNC | Option Ex | 1,000 | 2.55 | 2,550 |
| 2014-12-17 | RVNC | Sale | 1,000 | 16.45 | 16,450 |
| 2014-12-09 | RVNC | Option Ex | 500 | 2.55 | 1,275 |
| 2014-12-09 | RVNC | Sale | 500 | 18.00 | 9,000 |
| 2014-11-18 | RVNC | Sale | 1,000 | 16.00 | 16,000 |
| 2014-11-18 | RVNC | Option Ex | 1,000 | 2.55 | 2,550 |
| 2014-10-28 | RVNC | Option Ex | 500 | 2.55 | 1,275 |
| 2014-10-28 | RVNC | Sale | 500 | 20.00 | 10,000 |
| 2014-10-17 | RVNC | Option Ex | 1,500 | 2.55 | 3,824 |
| 2014-10-17 | RVNC | Sale | 1,500 | 18.54 | 27,814 |
| 2014-09-17 | RVNC | Option Ex | 1,162 | 2.55 | 2,963 |
| 2014-09-17 | RVNC | Sale | 2,000 | 20.54 | 41,074 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ruegg Curtis (EVP R&D and Tech Operations of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.